PCR partners with CAC for Prostate Cancer Awareness Month
31 August 2023
PCR partners with CAC for Prostate Cancer Awareness Month
Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data
24 August 2023
Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data
Exploring men’s psychological adjustment to prostate cancer
8 August 2023
Exploring men’s psychological adjustment to prostate cancer
Jeanette Ager Braves the Thames Marathon Swim for Prostate Cancer Research
1 August 2023
Jeanette Ager Braves the Thames Marathon Swim for Prostate Cancer Research
Prostate Cancer Research statement on the NCRI
26 June 2023
Prostate Cancer Research statement on the NCRI
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
18 May 2023
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
Nanovery secures over £1.85 million for cancer diagnostic solution
11 April 2023
Nanovery secures over £1.85 million for cancer diagnostic solution
Prostate Cancer Research gains PIF TICK accreditation to become a ‘trusted information creator’
28 March 2023
Prostate Cancer Research gains PIF TICK accreditation to become a ‘trusted information creator’
#GiveMenMoreTime – NICE reopens consultation on Pluvicto
2 March 2023
#GiveMenMoreTime – NICE reopens consultation on Pluvicto
Taking on a Run a Day: Issy Hughes’s 180 Kilometres March Challenge
24 February 2023
Taking on a Run a Day: Issy Hughes’s 180 Kilometres March Challenge
Load more